H.R. 2338 - To Amend the Federal Food, Drug, and Cosmetic Act to Provide for the Development and Use of Patient Experience Data to Enhance the Structured Risk-Benefit Assessment Framework, and for Other Purposes.
Health. 114th Congress (2015-2016) View bill details
- Sponsor:
- Joseph R. Pitts
- Summary:
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
There have been no votes on this bill.
To Amend the Federal Food, Drug, and Cosmetic Act to Provide for the Development and Use of Patient Experience Data to Enhance the Structured Risk-Benefit Assessment Framework, and for Other Purposes.
H.R. 2338 — 114th Congress (2015–2016)
- Summary
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
- Other Titles
- To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
- Sponsor
- Joseph R. Pitts
- Co-Sponsors
- Subjects
- Health
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Health information and medical records
- Medical research
- Research administration and funding
- Related Bills
- Major Actions
Introduced 5/14/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 5/14/2015 5/14/2015 Referred to the House Committee on Energy and Commerce. 5/14/2015 Introduced in House 5/15/2015 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Includes reported contributions to congressional campaigns of House members in office during the 114th U.S. Congress, from interest groups invested in the vote according to MapLight, November 29, 2014 – November 28, 2016.
Contributions data source: OpenSecrets.org
Contributions data source: OpenSecrets.org
